A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People
NCT06139315
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BI 765845
DRUG:
Placebo
Sponsor
Boehringer Ingelheim